These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7559103

  • 21. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R, Kobayashi K, Katsuno M, Kobayashi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [Abstract] [Full Text] [Related]

  • 22. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M, Navaglia F, Basso D, De Paoli M, Nicoletto MO, Maraglino E, Torre GC.
    Anticancer Res; 1996 Feb; 16(6B):3833-8. PubMed ID: 9042266
    [Abstract] [Full Text] [Related]

  • 23. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
    Nam JH, Cole LA, Chambers JT, Schwartz PE.
    Gynecol Oncol; 1990 Mar; 36(3):383-90. PubMed ID: 2318449
    [Abstract] [Full Text] [Related]

  • 24. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
    Cole LA, Nam JH.
    Yale J Biol Med; 1989 Mar; 62(4):367-78. PubMed ID: 2596125
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Qualitative analysis of the immunoreactive hCG beta-like substance produced by transitional cell carcinoma of the bladder].
    Yamanaka N, Nishimura R.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1150-6. PubMed ID: 1716709
    [Abstract] [Full Text] [Related]

  • 27. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
    Pokharel K, Gilbar PJ, Mansfield SK, Nair LM, So A.
    J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
    [Abstract] [Full Text] [Related]

  • 28. The origin of a human chorionic gonadotropin beta-subunit-core fragment excreted in the urine of patients with cancer.
    Papapetrou PD, Nicopoulou SC.
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):415-22. PubMed ID: 2428192
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
    Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhommé C, Rougier P.
    Cancer Res; 1992 Jul 15; 52(14):3901-7. PubMed ID: 1377600
    [Abstract] [Full Text] [Related]

  • 31. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
    Schwarz-Roeger U, Petzoldt B, Waldschmidt R, Walker RP, Bauknecht T, Kiechle M.
    Anticancer Res; 1997 Jul 15; 17(4B):3041-5. PubMed ID: 9329597
    [Abstract] [Full Text] [Related]

  • 32. Skin metastases of gynecologic adenocarcinomas affect serum levels of hCGbeta but not those of SCC antigen.
    Lehtovirta P, Alfthan H, Vartiainen J, Stenman U.
    Tumour Biol; 1999 Jul 15; 20(5):251-5. PubMed ID: 10436417
    [Abstract] [Full Text] [Related]

  • 33. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF, Schlatterer JP, Birken S, Krichevsky A, Armstrong EG, McMahon D, Canfield RE.
    Cancer Res; 1988 Mar 01; 48(5):1361-6. PubMed ID: 2449279
    [Abstract] [Full Text] [Related]

  • 34. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
    Vartiainen J, Lassus H, Lehtovirta P, Finne P, Alfthan H, Butzow R, Stenman UH.
    Int J Cancer; 2008 May 01; 122(9):2125-9. PubMed ID: 18098286
    [Abstract] [Full Text] [Related]

  • 35. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
    Nam JH, Chang KC, Chambers JT, Schwartz PE, Cole LA.
    Gynecol Oncol; 1990 Jul 01; 38(1):66-70. PubMed ID: 2354828
    [Abstract] [Full Text] [Related]

  • 36. The quagmire of hCG and hCG testing in gynecologic oncology.
    Muller CY, Cole LA.
    Gynecol Oncol; 2009 Mar 01; 112(3):663-72. PubMed ID: 19007977
    [Abstract] [Full Text] [Related]

  • 37. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D, Hirasawa A, Susumu N.
    Gan To Kagaku Ryoho; 2005 Mar 01; 32(3):411-6. PubMed ID: 15791829
    [Abstract] [Full Text] [Related]

  • 38. The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
    Sisinni L, Landriscina M.
    Adv Exp Med Biol; 2015 Mar 01; 867():159-76. PubMed ID: 26530366
    [Abstract] [Full Text] [Related]

  • 39. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE, Cracchiolo BM, Cole LA.
    Anticancer Res; 1996 Mar 01; 16(4B):2135-9. PubMed ID: 8694533
    [Abstract] [Full Text] [Related]

  • 40. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S, Katabuchi H, Araki M, Ohba T, Koizumi T, Okamura H, Nishimura R.
    Placenta; 2000 Jan 01; 21(1):79-87. PubMed ID: 10692255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.